Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Silvertown, Josh D.
Walia, Jagdeep S.
Summerlee, Alastair J.
and
Medin, Jeffrey A.
2006.
Functional Expression of Mouse Relaxin and Mouse Relaxin-3 in the Lung from an Ebola Virus Glycoprotein-Pseudotyped Lentivirus via Tracheal Delivery.
Endocrinology,
Vol. 147,
Issue. 8,
p.
3797.
Silvertown, Josh D.
Symes, Juliane C.
Neschadim, Anton
Nonaka, Takahiro
Kao, Jessica C. H.
Summerlee, Alastair J. S.
and
Medm, Jeffrey A.
2007.
Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth.
The FASEB Journal,
Vol. 21,
Issue. 3,
p.
754.
Barlos, Kostas K.
Gatos, Dimitrios
Vasileiou, Zoe
and
Barlos, Kleomenis
2010.
An optimized chemical synthesis of human relaxin‐2.
Journal of Peptide Science,
Vol. 16,
Issue. 4,
p.
200.
Sasser, Jennifer M.
Molnar, Miklos
and
Baylis, Chris
2011.
Relaxin Ameliorates Hypertension and Increases Nitric Oxide Metabolite Excretion in Angiotensin II But Not
N
ω
-Nitro-
l
-Arginine Methyl Ester Hypertensive Rats
.
Hypertension,
Vol. 58,
Issue. 2,
p.
197.
Conrad, Kirk P.
and
Shroff, Sanjeev G.
2011.
Effects of Relaxin on Arterial Dilation, Remodeling, and Mechanical Properties.
Current Hypertension Reports,
Vol. 13,
Issue. 6,
p.
409.
Debrah, Dan O.
Debrah, Julianna E.
Haney, Jamie L.
McGuane, Jonathan T.
Sacks, Michael S.
Conrad, Kirk P.
and
Shroff, Sanjeev G.
2011.
Relaxin regulates vascular wall remodeling and passive mechanical properties in mice.
Journal of Applied Physiology,
Vol. 111,
Issue. 1,
p.
260.
Ahmad, Nisar
Wang, Wei
Nair, Remi
and
Kapila, Sunil
2012.
Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: Induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathways.
Molecular and Cellular Endocrinology,
Vol. 363,
Issue. 1-2,
p.
46.
Kwok, Wai Him
Ho, Emmie N. M.
Leung, Gary N. W.
Wong, April S. Y.
Yue, Samuel K.
and
Wan, Terence S. M.
2013.
Identification of recombinant human relaxin‐2 in equine plasma by liquid chromatography‐high resolution mass spectrometry.
Drug Testing and Analysis,
Vol. 5,
Issue. 8,
p.
627.
Sasser, Jennifer M.
2013.
The emerging role of relaxin as a novel therapeutic pathway in the treatment of chronic kidney disease.
American Journal of Physiology-Regulatory, Integrative and Comparative Physiology,
Vol. 305,
Issue. 6,
p.
R559.
Yegorov, Sergey
Bogerd, Jan
and
Good, Sara V.
2014.
The relaxin family peptide receptors and their ligands: New developments and paradigms in the evolution from jawless fish to mammals.
General and Comparative Endocrinology,
Vol. 209,
Issue. ,
p.
93.